Researchers conducted a prospective, triple-blinded, randomized-controlled trial examining the use of dextrose combined with saline in the IV. The trial included 190 women. Patients were randomly assigned to receive either IV dextrose with normal saline or normal saline for the whole duration of induction, labor and delivery.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The dextrose group experienced reduced labor times compared to the non-dextrose group, 441 minutes versus 505 minutes. The proportion of patients who delivered at 200 minutes was 19 percent in the dextrose group versus 8 percent in the normal saline group. The proportion of patients who delivered at 450 minutes was 75 percent in the dextrose group versus 61 percent in the normal saline group.
More articles on healthcare quality:
UPMC finds mold at outsourced laundry facility; presents possible link to 5 patient deaths
CDC will not further investigate UPMC mold outbreak despite new report
Sepsis causes more readmissions than COPD, heart failure, heart attack and pneumonia
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.